Standout Papers

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised ... 2000 2026 2008 2017 2.3k
  1. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial (2002)
    James Shepherd, Gerard J. Blauw et al. The Lancet
  2. Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study (2003)
    Naveed Sattar, Allan Gaw et al. Circulation
  3. Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) (2001)
    A. Michael Wallace, Alex D. McMahon et al. Circulation
  4. Lipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart Disease (2000)
    Chris J. Packard, D S O’Reilly et al. New England Journal of Medicine
  5. C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study (2002)
    Dilys J. Freeman, John Norrie et al. Diabetes
  6. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study (2007)
    Scott Brouilette, J. Moore et al. The Lancet
  7. Overproduction of large VLDL particles is driven by increased liver fat content in man (2006)
    Martin Adiels, Marja‐Riitta Taskinen et al. Diabetologia
  8. Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease (2019)
    Brian A. Ference, John J.P. Kastelein et al. JAMA
  9. Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia (2022)
    Jan Borén, Marja‐Riitta Taskinen et al. Nature Reviews Cardiology
  10. Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK Biobank study (2023)
    Elias Björnson, Martin Adiels et al. European Heart Journal
  11. Lipoprotein(a) Is Markedly More Atherogenic Than LDL (2024)
    Elias Björnson, Martin Adiels et al. Journal of the American College of Cardiology

Immediate Impact

1 by Nobel laureates 2 from Science/Nature 143 standout
Sub-graph 1 of 14

Citing Papers

Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
2025 Standout
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
2024 Standout
17 intermediate papers

Works of Chris J. Packard being referenced

Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance
2023
Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
2019 Standout
and 14 more

Author Peers

Author Last Decade Papers Cites
Chris J. Packard 7876 7235 4657 204 18.5k
Allan D. Sniderman 7638 6326 4601 289 16.0k
H Bryan Brewer 9656 8157 4539 151 21.3k
Éric Bruckert 7463 5326 3254 378 17.1k
Harold Bays 9692 6931 3290 342 18.1k
D. Roger Illingworth 6854 6205 4042 162 17.8k
James M. McKenney 10019 7409 4894 154 20.7k
Anne Tybjærg‐Hansen 10644 9027 7161 341 27.4k
Samia Mora 5563 5178 4338 219 15.1k
Helen M. Colhoun 7813 8596 4058 273 18.6k
Michael H. Davidson 12546 8149 4396 414 22.4k

All Works

Loading papers...

Rankless by CCL
2026